Application of the MRC brain tumour prognostic index to patients with malignant glioma not managed in randomised control trial.
about
Age as an independent prognostic factor in patients with glioblastoma: a Radiation Therapy Oncology Group and American College of Surgeons National Cancer Data Base comparison.The proteomic response in glioblastoma in young patientsInhibition of platelet-derived growth factor signalling induces autophagy in malignant glioma cellsRandomized Phase III controlled trials of therapy in malignant glioma: where are we after 40 years?Predictors of long-term survival in patients with glioblastoma multiforme: advancements from the last quarter century.Parameters assessing neurological status in malignant glioma patients: prognostic value for survival and relapse-free time.
P2860
Application of the MRC brain tumour prognostic index to patients with malignant glioma not managed in randomised control trial.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Application of the MRC brain t ...... d in randomised control trial.
@ast
Application of the MRC brain t ...... d in randomised control trial.
@en
type
label
Application of the MRC brain t ...... d in randomised control trial.
@ast
Application of the MRC brain t ...... d in randomised control trial.
@en
prefLabel
Application of the MRC brain t ...... d in randomised control trial.
@ast
Application of the MRC brain t ...... d in randomised control trial.
@en
P2093
P2860
P356
P1476
Application of the MRC brain t ...... d in randomised control trial.
@en
P2093
P2860
P304
P356
10.1136/JNNP.64.6.747
P407
P577
1998-06-01T00:00:00Z